Prospects for targeting protein kinase C isozymes in the therapy of drug-resistant cancer - An evolving story

Cancer and Metastasis Reviews

Volumn 20, Issue 1-2, 2001, Pages 95-100

  O'Brian, Catherine A ^a   Ward, Nancy E ^a   Stewart, Jubilee R ^a   Chu, Feng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Drug induced apoptosis; Multidrug resistance (MDR); P glycoprotein (Pgp); Protein kinase C (PKC)

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; GLYCOPROTEIN P; ISOENZYME; MIDOSTAURIN; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; RESVERATROL; TAMOXIFEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMOSENSITIVITY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; ISOENZYMES; NEOPLASMS; PROTEIN KINASE C;

EID: 0035695214     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013186430906     Document Type: Article

References (54)

1. Protein kinase C isoenzymes: Regulation and function
2. New insights into the regulation of protein kinase C and novel phorbol ester receptors
3. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters
4. Transgenic mice overexpressing protein kinase Cδ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate
5. Transgenic mice overexpressing protein kinase Cε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion
6. Inhibition of protein kinase C by tamoxifen
7. Phorbol esters induce multidrug resistance in human breast cancer cells
8. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF 7 cells
9. P-glycoprotein: Its role in drug resistance
10. P-glycoprotein - A mediator of multidrug resistance in tumour cells
11. The contribution of protein kinase C to multiple drug resistance in cancer
12. Role of protein kinase C in multidrug resistance
13. Transient protection of cultured human cells against antitumor agents by 12-0-tetradecanoylphorbol-13-acetate
14. Effects of phorbol esters on doxorubicin transport systems
15. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro
16. In vitro model for intrinsic drug resistance: Effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells
17. 2- or pH
18. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-α (PKC-α) pseudosubstrate peptides through a P-glycoprotein-independent mechanism
19. Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein
20. 1 confers a multidrug-resistant phenotype on rat fibroblasts
21. Expression of the antisense cDNA for protein kinase C-α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells
22. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists
23. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C
24. Bacterial expression of the linker region of human MDR1 P-glycoprotein and mutational analysis of phosphorylation sites
25. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells
26. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein
27. P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells
28. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: A potential role for protein kinase C in reducing drug influx
29. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells
30. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance
31. P-glycoprotein, multidrug resistance and protein kinase C
32. The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance
33. Analogs of staurosporine: Potential anticancer drugs?
34. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
35. Multidrug resistance: Molecular mechanisms and clinical relevance
36. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide
37. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression
38. Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1-binding protein- 3
39. Phase I study of an antisense oligonucleotide to protein kinase C-α (ISIS 3521/CGP 64128A) in patients with cancer
40. Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer
41. Protein kinase C δ is essential for etoposide-induced apoptosis in salivary gland acinar cells
42. Involvement of protein kinase C δ (PKCδ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells
43. Mitochondrial translocation of protein kinase C δ in phorbol ester-induced cytochrome c release and apoptosis
44. Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis
45. Transgenic mice overexpressing protein kinase Cδ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate
46. Atypical protein kinase C ι protects human leukemia cells against drug-induced apoptosis
47. Protein kinase C ι activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis
48. Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance of the cytochrome c-mediated caspase-9 death pathway
49. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412
50. A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood
51. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism
52. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
53. Oxidant-induced S-glutathiolation inactivates protein kinase C-α (PKC-α): A potential mechanism of PKC isozyme regulation
54. Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor cysteine